Anand Rathi is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1915 in its research report dated January 27, 2023.

Buy Torrent Pharmaceuticals; target of Rs 1915: Anand Rathi

Sharekhan is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1788 in its research report dated January 27, 2023.

Buy Torrent Pharmaceuticals, target of Rs 1788: Sharekhan

Prabhudas Lilladher is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1820 in its research report dated January 26, 2023.

Buy Torrent Pharmaceuticals; target of Rs 1820: Prabhudas Lilladher

On consolidated basis, Torrent Pharmaceuticals’ net profit rose 13.7% to Rs 283 crore on 18.17% jump in net revenue from operations to Rs 2,491 crore in Q3 FY23 over Q3 FY22.

Torrent Pharma Q3 PAT rises 14% YoY to Rs 283 cr

Even the rest of world market witnessed strong growth during the quarter.

Torrent Pharma Q3 Results Review - Branded Generics, The U.S. Led Earnings Growth Revival: Motilal Oswal

Torrent Pharma said that the dividend is expected to be paid/ dispatched on or around 14th February, 2023

Pharma stock declares 280% dividend. Check payment date, other details

Torrent Pharma’s revenues came in at Rs 2,491 crore for the quarter under review. The Ebitda margins were at 29.1 per cent while gross margins were 71 per cent during Q3FY23

Torrent Pharma Q3 PAT up 14% to Rs 249 crore riding on India, Brazil

Posts 18% growth in revenues supported by branded markets

Torrent Pharma Q3 net up 14%

Torrent Pharma on Wednesday said its consolidated net profit increased by 14 per cent to Rs 283 crore in the third quarter ended December 31, 2022.

Torrent Pharma Q3 net profit up 14% to Rs 283 cr; interim dividend declared

Torrent Pharmaceuticals consolidated net profit rises 13.65% in the December 2022 quarter

Buzzing stocks: Tata Motors, Tata Elxsi, Tata Steel Long Products, Bajaj Auto, atteries, Arvind, Bajaj Auto, Blue Dart, Cipla, Ceat, Dr Reddy’s Lab, DLF, Embassy Office Parks REIT, Equitas Holdings, Go Fashion, Indian Bank, Jindal Saw, Patanjali Foods, Sundaram Clayton, Torrent Pharmaceuticals, Reli…

Stocks that will see action on January 25, 2023

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Financials growth has been moderate for a few years

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Torrent Pharmaceuticals Limited is engaged in the manufacture and sale of branded, as well as unbranded generic pharmaceutical products.